CRYM reduces P2C to PPCA

Stable Identifier
R-HSA-5693347
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

The ketimine reductase mu-crystallin protein (CRYM) is a key enzyme in the pipecolate pathway, which is the main lysine degradation pathway in the brain. One substrate from the pipecolate pathway that can be reduced by CRYM is piperideine-2-carboxylate (P2C) to L-pipecolic acid (PPCA) (Hallen et al 2015). CRYM is also a thyroid hormone binding protein, able to bind and transport 3,5,3'-triiodo-L-thyronine (T3) into nuclei and regulate thyroid hormone-related gene expression (Cheng et al. 2007).

Literature References
PubMed ID Title Journal Year
25931162 Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions

Hallen, A, Cooper, AJ, Jamie, JF, Karuso, P

Neurochem. Res. 2015
17242435 Crystal structure of human micro-crystallin complexed with NADPH

Cheng, Z, Sun, L, He, J, Gong, W

Protein Sci. 2007
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
thiomorpholine-carboxylate dehydrogenase activity of CRYM [peroxisomal matrix]
Physical Entity
Activity
Orthologous Events
Cross References
Rhea
Authored
Reviewed
Created